Bharat Biotech: Providing Covaxin for ₹150/dose to the govt is not possible in the long run
Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.
Jun 15, 2021, 16:36 PM IST
Rs 150 per dose not sustainable: Bharat Biotech demands higher price for Covaxin from Centre
Bharat Biotech has so far invested over Rs 500 crores at risk from its own resources for product development, clinical trials and setting up of manufacturing facilities for Covaxin.
Jun 15, 2021, 14:38 PM IST
Bharat Biotech fixes Covaxin's price, new price will be applicable from May 1
Bharat Biotech has fixed the price of one dose of its Corona Vaccine 'Covaxin'. The company has kept the price of one dose different for the state government and private hospitals.
Apr 25, 2021, 07:54 AM IST
